2 hours Needham & Company LLC Reiterates “Hold” Rating for Sage Therapeutics (NASDAQ:SAGE) MarketBeat
Needham & Company LLC reiterated a “hold” rating on shares of Sage Therapeutics in a report on Tuesday.
Needham & Company LLC reiterated a “hold” rating on shares of Sage Therapeutics in a report on Tuesday.